Back to Search
Start Over
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
- Source :
- Clinical gastroenterology and hepatology, 18 (4, Fernández, J, Angeli, P, Trebicka, J, Merli, M, Gustot, T, Alessandria, C, Aagaard, N K, de Gottardi, A, Welzel, T M, Gerbes, A, Soriano, G, Vargas, V, Albillos, A, Salerno, F, Durand, F, Bañares, R, Stauber, R, Prado, V, Arteaga, M, Hernández-Tejero, M, Aziz, F, Morando, F, Jansen, C, Lattanzi, B, Moreno, C, Campion, D, Gronbaek, H, Garcia, R, Sánchez, C, García, E, Amorós, A, Pavesi, M, Clària, J, Moreau, R & Arroyo, V 2020, ' Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis ', Clinical Gastroenterology and Hepatology, vol. 18, no. 4, pp. 963-973.e14 . https://doi.org/10.1016/j.cgh.2019.07.055, Dipòsit Digital de la UB, Universidad de Barcelona
- Publication Year :
- 2019
-
Abstract
- Background & Aims: We performed a randomized trial to determine whether albumin should be administered to patients with infections unrelated to spontaneous bacterial peritonitis (SBP). Methods: We performed a multicenter, open-label trial in which 118 patients with cirrhosis, non-SBP infections, and additional risk factors for poor outcome were randomly assigned to receive antibiotics plus albumin (study group; n = 61) or antibiotics alone (control group; n = 57). The primary outcome was in-hospital mortality; secondary outcomes were effect of albumin on disease course. Results: There were no significant differences at baseline between groups in results from standard laboratory tests, serum markers of inflammation, circulatory dysfunction, or liver severity scores. However, the combined prevalence of acute on chronic liver failure (ACLF) and kidney dysfunction was significantly higher in the study group (44.3% vs 24.6% in the control group; P = .02), indicating greater baseline overall severity. There was no significant difference in the primary outcome between groups (13.1% in the study group vs 10.5% in the control group; P = .66). Circulatory and renal functions improved in only the study group. A significantly higher proportion of patients in the study group had resolution of ACLF (82.3% vs 33.3% in the control group; P = .03). A significantly lower proportion of patients in the study group developed nosocomial infections (6.6% vs 24.6% in the control group; P = .007). Conclusions: In a randomized trial of patients with advanced cirrhosis and non-SBP infections, in-hospital mortality was similar between those who received albumin plus antibiotics vs those who received only antibiotics (controls). However, patients given albumin were sicker at baseline and, during the follow-up period, a higher proportion had ACLF resolution and a lower proportion had nosocomial infections. ClinicalTrials.gov no: NCT02034279.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published
- Subjects :
- Liver Cirrhosis
Cirrhosis
Nosocomial Infections
Antibiotics
Communicable diseases
Gastroenterology
law.invention
0302 clinical medicine
immune-modulation
Randomized controlled trial
Hepatorenal syndrome
law
Albúmines
Gastro-entérologie
610 Medicine & health
Acute-on-Chronic Liver Failure
biology
Immune-Modulation
Mortality
acute-on-chronic liver failure
mortality
nosocomial infections
albumins
humans
liver cirrhosis
bacterial infections
peritonitis
Bacterial Infections
Hepatic cirrhosis
030220 oncology & carcinogenesis
Anti-infective agents
030211 gastroenterology & hepatology
medicine.medical_specialty
Agents antiinfecciosos
Cirrosi hepàtica
medicine.drug_class
Peritonitis
03 medical and health sciences
Spontaneous bacterial peritonitis
Internal medicine
Albumins
medicine
Humans
Intention-to-treat analysis
Hepatology
business.industry
C-reactive protein
Albumin
Acute-On-Chronic Liver Failure
Malalties infeccioses
medicine.disease
biology.protein
business
Subjects
Details
- ISSN :
- 15427714
- Volume :
- 18
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
- Accession number :
- edsair.doi.dedup.....829e0529f3e51526e4af016ca2bbf0b4
- Full Text :
- https://doi.org/10.1016/j.cgh.2019.07.055